BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 36889914)

  • 21. Investigating point-of-care diagnostics for sexually transmitted infections and antimicrobial resistance in antenatal care in Zimbabwe (IPSAZ): protocol for a mixed-methods study.
    Martin K; Dziva Chikwari C; Dauya E; Mackworth-Young CRS; Bath D; Tucker J; Simms V; Bandason T; Ndowa F; Katsidzira L; Mugurungi O; Machiha A; Marks M; Kranzer K; Ferrand R
    BMJ Open; 2023 Apr; 13(4):e070889. PubMed ID: 37080628
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Burden of sexually transmitted infections from acute HIV infection among women in South Africa: Evidence from a prospective cohort study.
    Asare K; Osman F; Ngcapu S; Vandormael A; Naicker N; Khanyile M; Mindel A; Abdool Karim SS; Tomita A; Garrett N
    Ann Epidemiol; 2022 Oct; 74():132-139. PubMed ID: 35977656
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and incidence of sexually transmitted infections among South African women initiating injectable and long-acting contraceptives.
    Harryparsad R; Meyer B; Taku O; Serrano M; Chen PL; Gao X; Williamson AL; Mehou-Loko C; d'Hellencourt FL; Smit J; Strauss J; Nanda K; Ahmed K; Beksinska M; Buck G; Morrison C; Deese J; Masson L
    PLoS One; 2023; 18(11):e0294285. PubMed ID: 37948399
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mother-to-child transmission of Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis in HIV-infected pregnant women in South Africa.
    Peters RP; Feucht UD; de Vos L; Ngwepe P; McIntyre JA; Klausner JD; Medina-Marino A
    Int J STD AIDS; 2021 Aug; 32(9):799-805. PubMed ID: 33769901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sexual behaviour and incidence of HIV and sexually transmitted infections among men who have sex with men using daily and event-driven pre-exposure prophylaxis in AMPrEP: 2 year results from a demonstration study.
    Hoornenborg E; Coyer L; Achterbergh RCA; Matser A; Schim van der Loeff MF; Boyd A; van Duijnhoven YTHP; Bruisten S; Oostvogel P; Davidovich U; Hogewoning A; Prins M; de Vries HJC;
    Lancet HIV; 2019 Jul; 6(7):e447-e455. PubMed ID: 31178284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Global Epidemiologic Characteristics of Sexually Transmitted Infections Among Individuals Using Preexposure Prophylaxis for the Prevention of HIV Infection: A Systematic Review and Meta-analysis.
    Ong JJ; Baggaley RC; Wi TE; Tucker JD; Fu H; Smith MK; Rafael S; Anglade V; Falconer J; Ofori-Asenso R; Terris-Prestholt F; Hodges-Mameletzis I; Mayaud P
    JAMA Netw Open; 2019 Dec; 2(12):e1917134. PubMed ID: 31825501
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.
    Traeger MW; Cornelisse VJ; Asselin J; Price B; Roth NJ; Willcox J; Tee BK; Fairley CK; Chang CC; Armishaw J; Vujovic O; Penn M; Cundill P; Forgan-Smith G; Gall J; Pickett C; Lal L; Mak A; Spelman TD; Nguyen L; Murphy DA; Ryan KE; El-Hayek C; West M; Ruth S; Batrouney C; Lockwood JT; Hoy JF; Hellard ME; Stoové MA; Wright EJ;
    JAMA; 2019 Apr; 321(14):1380-1390. PubMed ID: 30964528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sexually transmitted infections incidence in young Thai men who have sex with men and transgender women using HIV pre-exposure prophylaxis.
    Songtaweesin WN; Pornpaisalsakul K; Kawichai S; Wacharachaisurapol N; Wongharn P; Yodkitudomying C; Panichnantakul P; Theerawit T; Pankam T; Puthanakit T
    Int J STD AIDS; 2022 Apr; 33(5):447-455. PubMed ID: 35282719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. African women recently infected with HIV-1 and HSV-2 have increased risk of acquiring Neisseria gonorrhoeae and Chlamydia trachomatis in the Methods for Improving Reproductive Health in Africa trial.
    Venkatesh KK; van der Straten A; Mayer KH; Blanchard K; Ramjee G; Lurie MN; Chipato T; Padian NS; de Bruyn G
    Sex Transm Dis; 2011 Jun; 38(6):562-70. PubMed ID: 21278624
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African Women.
    Kiweewa FM; Brown E; Mishra A; Nair G; Palanee-Phillips T; Mgodi N; Nakabiito C; Chakhtoura N; Hillier SL; Baeten JM;
    J Int AIDS Soc; 2019 Feb; 22(2):e25257. PubMed ID: 30816632
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of aetiological screening of sexually transmitted infections during pregnancy on pregnancy outcomes in South Africa.
    Nyemba DC; Peters RPH; Medina-Marino A; Klausner JD; Ngwepe P; Myer L; Johnson LF; Joseph Davey DL
    BMC Pregnancy Childbirth; 2022 Mar; 22(1):194. PubMed ID: 35264142
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of Trends in Rates of Sexually Transmitted Infections Before vs After Initiation of HIV Preexposure Prophylaxis Among Men Who Have Sex With Men.
    McManus H; Grulich AE; Amin J; Selvey C; Vickers T; Bavinton B; Zablotska I; Vaccher S; Jin F; Holden J; Price K; Yeung B; Cabrera Quichua G; Ogilvie E; McNulty A; Smith D; Guy R
    JAMA Netw Open; 2020 Dec; 3(12):e2030806. PubMed ID: 33355675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Doxycycline post-exposure prophylaxis for prevention of sexually transmitted infections among Kenyan women using HIV pre-exposure prophylaxis: study protocol for an open-label randomized trial.
    Stewart J; Bukusi E; Sesay FA; Oware K; Donnell D; Soge OO; Celum C; Odoyo J; Kwena ZA; Scoville CW; Violette LR; Morrison S; Simoni J; McClelland RS; Barnabas R; Gandhi M; Baeten JM
    Trials; 2022 Jun; 23(1):495. PubMed ID: 35710444
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Point-of-Care Testing on the Management of Sexually Transmitted Infections in South Africa: Evidence from the HVTN702 Human Immunodeficiency Virus Vaccine Trial.
    Asare K; Andine T; Naicker N; Dorward J; Singh N; Spooner E; Andriesen J; Osman F; Ngcapu S; Vandormael A; Mindel A; Abdool Karim SS; Bekker LG; Gray G; Corey L; Tomita A; Garrett N
    Clin Infect Dis; 2023 Mar; 76(5):881-889. PubMed ID: 36250382
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Using partner notification to address curable sexually transmitted infections in a high HIV prevalence context: a qualitative study about partner notification in Botswana.
    Wynn A; Moucheraud C; Moshashane N; Offorjebe OA; Ramogola-Masire D; Klausner JD; Morroni C
    BMC Public Health; 2019 May; 19(Suppl 1):606. PubMed ID: 31138228
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV pre-exposure prophylaxis was associated with no impact on sexually transmitted infection prevalence in a high-prevalence population of predominantly men who have sex with men, Germany, 2018 to 2019.
    Streeck H; Jansen K; Crowell TA; Esber A; Jessen HK; Cordes C; Scholten S; Schneeweiss S; Brockmeyer N; Spinner CD; Bickel M; Esser S; Hartikainen J; Stoehr A; Lehmann C; Marcus U; Vehreschild JJ; Knorr A; Brillen AL; Tiemann C; Robb ML; Michael NL
    Euro Surveill; 2022 Apr; 27(14):. PubMed ID: 35393933
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incentives conditioned on tenofovir levels to support PrEP adherence among young South African women: a randomized trial.
    Celum CL; Gill K; Morton JF; Stein G; Myers L; Thomas KK; McConnell M; van der Straten A; Baeten JM; Duyver M; Mendel E; Naidoo K; Dallimore J; Wiesner L; Bekker LG
    J Int AIDS Soc; 2020 Nov; 23(11):e25636. PubMed ID: 33247553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acceptability, feasibility and cost of point of care testing for sexually transmitted infections among South African adolescents where syndromic management is standard of care.
    Marcus R; C P; Gill K; Smith P; Rouhani S; Mendelsohn A; Mendel E; Lince-Deroche N; Naidoo K; Ahmed N; Stirrup O; Roseleur J; Leuner R; Meyer-Rath G; Bekker LG
    BMC Health Serv Res; 2023 Oct; 23(1):1078. PubMed ID: 37817160
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of a tool to assess HIV prevention readiness of adolescent girls and young women in HPTN 082 study.
    Beauchamp G; Hosek S; Donnell DJ; Chan KCG; Flaherty BP; Anderson PL; Dye BJ; Mgodi N; Bekker LG; Delany-Moretlwe S; Celum C;
    PLoS One; 2023; 18(2):e0281728. PubMed ID: 36827440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemsex and incidence of sexually transmitted infections among Canadian pre-exposure prophylaxis (PrEP) users in the l'Actuel PrEP Cohort (2013-2020).
    Flores Anato JL; Panagiotoglou D; Greenwald ZR; Blanchette M; Trottier C; Vaziri M; Charest L; Szabo J; Thomas R; Maheu-Giroux M
    Sex Transm Infect; 2022 Dec; 98(8):549-556. PubMed ID: 35039437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.